Health Care/Hospital

Nanoform and Boehringer Ingelheim execute master services agreement

HELSINKI, Aug. 3, 2021 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform's award-winning CESS® technology can deliver to its drug development proj...

2021-08-03 14:28

GenScript Joins Forces with Allozymes by Providing Smart Libraries Construction for Precision Protein Engineering

SINGAPORE, Aug. 3, 2021 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK) today announced a collaboration with Allozymes, a synthetic biology company transforming ingredient manufacturing by unlocking protein engineering potential through groundbreaking technologies. In this par...

2021-08-03 12:05 449

Jacobio Announces First Patient Dosed in Phase I/II Clinical Trial of KRAS G12C Inhibitor for Solid Tumor

BEIJING, Aug. 3, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) today announced the first patient was dosed in a Phase I/II clinical trial of KRAS G12C inhibitor JAB-21822 inChina. JAB-21822 is Jacobio's innovative in-house small molecule anti-cancer drug, which is designed to target t...

2021-08-03 09:00 509

CStone announces positive registrational study of the first-in-class drug ivosidenib in Chinese patients with relapsed or refractory acute myeloid leukemia, and NDA has been accepted by the China NMPA and considered for Priority Review

* Ivosidenib (TIBSOVO®, the brand name in the U.S.) is the first isocitrate dehydrogenase 1 (IDH1) inhibitor inChina that has demonstrated its efficacy and manageable safety in patients with relapsed or refractory acute myeloid leukemia (R/R AML) * The National Medical Products Administration...

2021-08-03 08:05 678

Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus

HANGZHOU, China, Aug. 3, 2021 /PRNewswire/ -- Insilico Medicine and Westlake Pharma announced a strategic partnership to jointly develop innovative small-molecule drugs for Novel Coronavirus (COVID-19) today. Insilico Medicin...

2021-08-03 08:00 538

Cardinal Health completes sale of Cordis business to Hellman & Friedman

DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately$1 billion includes the buyer's assumption of certain lia...

2021-08-02 23:00 979

SI Group Ranks in the Top 5 Percent for Global Corporate Social Responsibility

Company Awarded Gold Rating by EcoVadis for its Sustainability Commitment SCHENECTADY, N.Y., Aug. 2, 2021 /PRNewswire/ -- SI Group, a global leader in the innovative technology of performance additives, process solutions, active pharmaceutical ingredients, and chemical intermediates, has received...

2021-08-02 22:33 708

Vision Impact Institute Applauds UN Resolution on Vision

Resolution highlights impact of good vision to achieving the Sustainable Development Goals DALLAS, Aug. 2, 2021 /PRNewswire/ -- The Vision Impact Institute applauds the UN General Assembly's adoption of theVision for Everyone: accelerating action to achieve the Sustainable Development Goals reso...

2021-08-02 22:30 685

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

SUZHOU, China, Aug. 2, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that only 13 months after receiving its first GMP certificate, it has once again received a European Medicines Agency (EMA) GMP c...

2021-08-02 20:13 693

Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

* Nitric oxide has antimicrobial properties with direct proven effect on SARS-CoV-2 * Nitric Oxide Nasal Spray (NONS) has been tested in healthy volunteers and patients as part of UK andCanada clinical trials1 MUMBAI, India and VANCOUVER, BC, Aug. 2, 2021 /PRNewswire/ -- Glenmark Pharmaceutic...

2021-08-02 18:45 631

ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO

MILAN, Aug. 2, 2021 /PRNewswire/ -- ElectroPhysiology Frontiers S.p.A. (EPF), announced that its Board of Directors unanimously appointedAvi Fischer, M.D. as Chief Executive Officer (CEO) of the company and a member of its Board of Directors. EPF is a medical technology company developing an inn...

2021-08-02 18:00 533

Hummingbird Bioscience Announces UK MHRA Approval for First-in-Human Phase 1 Trial of HMBD-001 in Advanced Cancers

HOUSTON and SINGAPORE, Aug. 2, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

2021-08-02 17:00 566

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye® RLP

STOCKHOLM, Aug. 2, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Southern Airlines has approved the Envirotainer Releye® RLP for usage on their fleet of aircrafts. With this approval...

2021-08-02 14:28 580

Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

TIBSOVO is the first targeted therapy to show improved event-free survival and overall survival in combination with azacitidine compared to azacitidine monotherapy. Safety profile consistent with previously published data in patients with IDH1-mutated acute myeloid leukemia. The study recently ...

2021-08-02 14:00 581

Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in Asia Pacific and Improving Access to Evidence-Based Medical Treatments for Mental Health

SUBANG JAYA, Malaysia, Aug. 2, 2021 /PRNewswire/ -- Luye Pharma Group today announced that it has entered into an agreement with Zuellig Pharma, a leading healthcare service group inAsia, under which the company grants Zuellig Pharma exclusive rights to distribute its central nervous system drugs...

2021-08-02 10:25 1227

JAPSC: Journal of Asian Pacific Society of Cardiology Launches and Welcomes Submissions

LONDON, Aug. 2, 2021 /PRNewswire/ -- The Radcliffe Group is pleased to announce thatJAPSC: Journal of Asian Pacific Society of Cardiology is now open to submissions. Welcoming original research, review articles, expert opinion pieces and case reports across all aspects of cardiovascular disease. ...

2021-08-02 09:26 561

Understanding the Pandemic Stress Level in Singapore

SINGAPORE, Aug. 2, 2021 /PRNewswire/ -- To better understand how stress is affecting Singaporeans during the pandemic, Traveloka conducted the 2021 Traveloka Wellness Survey with Singaporean respondents, covering all regions of the island, races, jobs, and genders. Stress is an inevitable part ...

2021-08-02 09:00 566

Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma

SEOUL, South Korea and SHANGHAI and HONG KONG, Aug. 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics i...

2021-08-02 07:29 2535

Rey Announces $10 Million in New Series A Funding to Expand Access to Mental Health through Digital Capabilities

Led by Optum Ventures and Oxford Sciences Innovation, new funding will propel Rey's launch of a tech-enabled, on-demand mental health clinic in response to growing demand for high-quality care in an increasingly resource constrained market AUSTIN, Texas, July 31, 2021 /PRNewswire/ -- Rey, a new ...

2021-07-31 02:56 2582

One More Apartment for Lucky Draw if Five Million Hong Kong Residents Vaccinated by 30 September 2021

HONG KONG, July 30, 2021 /PRNewswire/ -- Inspired by the heroic efforts of our Hong Kong Olympians inTokyo, the grit, determination, teamwork and unity displayed by each and every one of them, the sponsors (Ng Teng Fong Charitable Foundation Limited, the philanthropic arm of Sino Group, and Chine...

2021-07-30 18:03 1098
12345 ... 436